N. B. Gubergrits

941 total citations
52 papers, 441 citations indexed

About

N. B. Gubergrits is a scholar working on Surgery, Epidemiology and Genetics. According to data from OpenAlex, N. B. Gubergrits has authored 52 papers receiving a total of 441 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Surgery, 13 papers in Epidemiology and 11 papers in Genetics. Recurrent topics in N. B. Gubergrits's work include Pancreatitis Pathology and Treatment (23 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Digestive system and related health (8 papers). N. B. Gubergrits is often cited by papers focused on Pancreatitis Pathology and Treatment (23 papers), Pancreatic and Hepatic Oncology Research (9 papers) and Digestive system and related health (8 papers). N. B. Gubergrits collaborates with scholars based in Ukraine, Kazakhstan and Germany. N. B. Gubergrits's co-authors include Prabhakar Boddu, William J. Sandborn, Michael A. Kamm, Gary R. Lichtenstein, Kirstin Lees, Todd Butler, Raymond E. Joseph, Suntje Sander‐Struckmeier, Steven Caras and Yan Shen and has published in prestigious journals such as SHILAP Revista de lepidopterología, The American Journal of Gastroenterology and World Journal of Gastroenterology.

In The Last Decade

N. B. Gubergrits

33 papers receiving 425 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. B. Gubergrits Ukraine 7 245 209 201 137 49 52 441
Prabhakar Boddu India 7 115 0.5× 205 1.0× 248 1.2× 32 0.2× 49 1.0× 10 352
Danny J. Avalos United States 9 88 0.4× 122 0.6× 173 0.9× 71 0.5× 36 0.7× 24 328
Fiona D M van Schaik Netherlands 12 106 0.4× 286 1.4× 212 1.1× 97 0.7× 33 0.7× 15 449
Armando Peixoto Portugal 12 216 0.9× 37 0.2× 90 0.4× 78 0.6× 13 0.3× 66 425
Mehrdad Kashifard Iran 9 100 0.4× 96 0.5× 67 0.3× 19 0.1× 71 1.4× 27 320
Johanna Simin Sweden 10 38 0.2× 67 0.3× 63 0.3× 77 0.6× 38 0.8× 16 308
Mutaz Sultan United States 11 140 0.6× 40 0.2× 41 0.2× 104 0.8× 13 0.3× 21 348
R Schiöler Sweden 6 149 0.6× 302 1.4× 276 1.4× 31 0.2× 20 0.4× 7 373
C Sategna-Guidetti Italy 12 178 0.7× 175 0.8× 200 1.0× 49 0.4× 24 0.5× 23 451
Jean-Louis Gineston France 8 197 0.8× 126 0.6× 119 0.6× 20 0.1× 24 0.5× 12 356

Countries citing papers authored by N. B. Gubergrits

Since Specialization
Citations

This map shows the geographic impact of N. B. Gubergrits's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. B. Gubergrits with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. B. Gubergrits more than expected).

Fields of papers citing papers by N. B. Gubergrits

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. B. Gubergrits. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. B. Gubergrits. The network helps show where N. B. Gubergrits may publish in the future.

Co-authorship network of co-authors of N. B. Gubergrits

This figure shows the co-authorship network connecting the top 25 collaborators of N. B. Gubergrits. A scholar is included among the top collaborators of N. B. Gubergrits based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. B. Gubergrits. N. B. Gubergrits is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gubergrits, N. B., et al.. (2024). Organ-specific metastasis: an in vitro model for predicting the course of disease. 65(4). 54–59. 1 indexed citations
2.
3.
Gubergrits, N. B., et al.. (2024). Pancreas in the elderly and senile age. 62(1). 4–14.
4.
Domínguez‐Muñoz, J. Enrique, Miroslav Vujasinović, Daniel de la Iglesia, et al.. (2024). European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence‐based recommendations. United European Gastroenterology Journal. 13(1). 125–172. 17 indexed citations
5.
Gubergrits, N. B., et al.. (2023). Pancreatic syphilis mimicking cancer. 59(2). 35–38. 1 indexed citations
6.
7.
8.
9.
Gubergrits, N. B.. (2023). NSAID-esophagitis: how to break the vicious circles of pathogenesis? Clinical case. 37–50. 1 indexed citations
10.
Gubergrits, N. B., et al.. (2023). Relief of symptoms of gastric and intestinal dyspepsia in chronic pancreatitis. 60(3). 45–50. 1 indexed citations
11.
12.
Gubergrits, N. B., et al.. (2021). Bile in excess. 1 indexed citations
13.
Gubergrits, N. B., et al.. (2020). Secrets, puzzles and mysteries of macroamylasemia. 46(1). 12–22. 1 indexed citations
14.
Маев, И. В., et al.. (2020). Differences in In Vitro Properties of Pancreatin Preparations for Pancreatic Exocrine Insufficiency as Marketed in Russia and CIS. Drugs in R&D. 20(4). 369–376. 10 indexed citations
15.
Gubergrits, N. B., et al.. (2020). The final «battle» of the great commander. 0(6). 60–63.
16.
Layer, Peter, N. Kashirskaya, & N. B. Gubergrits. (2019). Contribution of pancreatic enzyme replacement therapy to survival and quality of life in patients with pancreatic exocrine insufficiency. World Journal of Gastroenterology. 25(20). 2430–2441. 35 indexed citations
17.
Gubergrits, N. B., et al.. (2019). Early chronic pancreatitis: is a clinical diagnosis possible?. 44(3). 33–41. 1 indexed citations
18.
Gubergrits, N. B., et al.. (2019). Exocrine pancreatic insufficiency in diabetes mellitus: frequency, pathogenesis, diagnosis, treatment. 44(3). 7–22. 1 indexed citations
19.
Gubergrits, N. B., et al.. (2015). The Risk of Contracting Drug-Induced Pancreatitis during Treatment for Pulmonary Tuberculosis. JOP, journal of the pancreas. 16(3). 278–282.
20.
Whitcomb, David C., Ewa Małecka‐Panas, N. B. Gubergrits, et al.. (2010). Effect of Underlying Disease Type on Efficacy and Safety of Pancrelipase Delayed-Release Capsules (CREON®) in a Randomized Trial of Patients with Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis or Pancreatic Surgery. The American Journal of Gastroenterology. 105. S51–S52. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Prabhakar Boddu Breakdown of academic impact, for papers by Danny J. Avalos Breakdown of academic impact, for papers by Fiona D M van Schaik Breakdown of academic impact, for papers by Armando Peixoto Breakdown of academic impact, for papers by Mehrdad Kashifard Breakdown of academic impact, for papers by Johanna Simin Breakdown of academic impact, for papers by Mutaz Sultan Breakdown of academic impact, for papers by R Schiöler Breakdown of academic impact, for papers by C Sategna-Guidetti Breakdown of academic impact, for papers by Jean-Louis Gineston
Rankless by CCL
2026